IRIS Accounts Production v23.2.0.158 10585223 director 1.2.22 31.1.23 31.1.23 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh105852232022-01-31105852232023-01-31105852232022-02-012023-01-31105852232021-01-31105852232021-02-012022-01-31105852232022-01-3110585223ns10:Originalns15:EnglandWales2022-02-012023-01-3110585223ns14:PoundSterlingns10:Original2022-02-012023-01-3110585223ns10:Originalns10:Director12022-02-012023-01-3110585223ns10:Original2022-02-012023-01-3110585223ns10:Original2023-01-3110585223ns10:Originalns10:PrivateLimitedCompanyLtd2022-02-012023-01-3110585223ns10:Originalns10:SmallEntities2022-02-012023-01-3110585223ns10:Originalns10:AuditExempt-NoAccountantsReport2022-02-012023-01-3110585223ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-02-012023-01-3110585223ns10:SmallCompaniesRegimeForAccountsns10:Original2022-02-012023-01-3110585223ns10:Originalns10:FullAccounts2022-02-012023-01-3110585223ns10:Original12022-02-012023-01-3110585223ns10:Originalns10:RegisteredOffice2022-02-012023-01-3110585223ns10:Original2022-01-3110585223ns10:Originalns5:CurrentFinancialInstruments2023-01-3110585223ns10:Originalns5:CurrentFinancialInstruments2022-01-3110585223ns10:Originalns5:Non-currentFinancialInstruments2023-01-3110585223ns10:Originalns5:Non-currentFinancialInstruments2022-01-3110585223ns5:ShareCapitalns10:Original2023-01-3110585223ns5:ShareCapitalns10:Original2022-01-3110585223ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-01-3110585223ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-01-3110585223ns10:Originalns5:NetGoodwill2022-02-012023-01-3110585223ns5:IntangibleAssetsOtherThanGoodwillns10:Original2022-02-012023-01-3110585223ns10:Originalns5:PlantMachinery2022-02-012023-01-3110585223ns10:Originalns5:FurnitureFittings2022-02-012023-01-3110585223ns10:Originalns5:ComputerEquipment2022-02-012023-01-3110585223ns10:Original2021-02-012022-01-3110585223ns10:Originalns5:NetGoodwill2022-01-3110585223ns10:Originalns5:NetGoodwill2023-01-3110585223ns10:Originalns5:NetGoodwill2022-01-3110585223ns10:Originalns5:PlantMachinery2022-01-3110585223ns10:Originalns5:FurnitureFittings2022-01-3110585223ns10:Originalns5:ComputerEquipment2022-01-3110585223ns10:Original2022-01-3110585223ns10:Originalns5:PlantMachinery2023-01-3110585223ns10:Originalns5:FurnitureFittings2023-01-3110585223ns10:Originalns5:ComputerEquipment2023-01-3110585223ns10:Originalns5:PlantMachinery2022-01-3110585223ns10:Originalns5:FurnitureFittings2022-01-3110585223ns10:Originalns5:ComputerEquipment2022-01-3110585223ns10:Originalns5:Non-currentFinancialInstrumentsns5:MoreThanFiveYears2023-01-3110585223ns10:Originalns5:Non-currentFinancialInstrumentsns5:MoreThanFiveYears2022-01-31
REGISTERED NUMBER: 10585223 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 January 2023

for

Carbonlite Medical Technology Ltd

Carbonlite Medical Technology Ltd (Registered number: 10585223)






Contents of the Financial Statements
for the Year Ended 31 January 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Carbonlite Medical Technology Ltd

Company Information
for the Year Ended 31 January 2023







DIRECTOR: S Khan





REGISTERED OFFICE: 20-22 Wenlock Road
London
N1 7GU





REGISTERED NUMBER: 10585223 (England and Wales)






Carbonlite Medical Technology Ltd (Registered number: 10585223)

Balance Sheet
31 January 2023

31.1.23 31.1.22
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 85,000 93,500
Tangible assets 5 20,760 24,826
105,760 118,326

CURRENT ASSETS
Stocks 70,250 74,220
Debtors 6 27,750 34,749
Cash at bank and in hand 5,379 9,672
103,379 118,641
CREDITORS
Amounts falling due within one year 7 15,383 31,481
NET CURRENT ASSETS 87,996 87,160
TOTAL ASSETS LESS CURRENT LIABILITIES 193,756 205,486

CREDITORS
Amounts falling due after more than one
year

8

193,739

204,567
NET ASSETS 17 919

CAPITAL AND RESERVES
Called up share capital 1 1
Retained earnings 16 918
SHAREHOLDERS' FUNDS 17 919

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Carbonlite Medical Technology Ltd (Registered number: 10585223)

Balance Sheet - continued
31 January 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 28 November 2023 and were signed by:





S Khan - Director


Carbonlite Medical Technology Ltd (Registered number: 10585223)

Notes to the Financial Statements
for the Year Ended 31 January 2023

1. STATUTORY INFORMATION

Carbonlite Medical Technology Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2017, is being amortised evenly over its estimated useful life of twenty years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 10% on cost
Fixtures and fittings - 10% on cost
Computer equipment - 25% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2022 - 1 ) .

Carbonlite Medical Technology Ltd (Registered number: 10585223)

Notes to the Financial Statements - continued
for the Year Ended 31 January 2023

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 February 2022
and 31 January 2023 170,000
AMORTISATION
At 1 February 2022 76,500
Charge for year 8,500
At 31 January 2023 85,000
NET BOOK VALUE
At 31 January 2023 85,000
At 31 January 2022 93,500

5. TANGIBLE FIXED ASSETS
Fixtures
Plant and and Computer
machinery fittings equipment Totals
£    £    £    £   
COST
At 1 February 2022 26,220 14,443 9,300 49,963
Disposals - - (9,300 ) (9,300 )
At 31 January 2023 26,220 14,443 - 40,663
DEPRECIATION
At 1 February 2022 7,217 8,620 9,300 25,137
Charge for year 2,622 1,444 - 4,066
Eliminated on disposal - - (9,300 ) (9,300 )
At 31 January 2023 9,839 10,064 - 19,903
NET BOOK VALUE
At 31 January 2023 16,381 4,379 - 20,760
At 31 January 2022 19,003 5,823 - 24,826

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.1.23 31.1.22
£    £   
Trade debtors 27,750 34,749

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.1.23 31.1.22
£    £   
Bank loans and overdrafts 7,577 -
Tax 4,770 3,684
Social security and other taxes 153 257
VAT 1,133 850
Directors' current accounts - 24,940
Accrued expenses 1,750 1,750
15,383 31,481

Carbonlite Medical Technology Ltd (Registered number: 10585223)

Notes to the Financial Statements - continued
for the Year Ended 31 January 2023

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
31.1.23 31.1.22
£    £   
Other loans - 2-5 years 15,031 25,859
Directors loan account 178,708 178,708
193,739 204,567